UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 27,
Vascular Biogenics (NASDAQ:VBLT)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Vascular Biogenics Charts.
Vascular Biogenics (NASDAQ:VBLT)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Vascular Biogenics Charts.

Vascular Biogenics Ltd. News

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 20 April 2024 (2 weeks ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 12 April 2024 (3 weeks ago) • Edgar (US Regulatory)
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 12 April 2024 (3 weeks ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 10 April 2024 (3 weeks ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 9 April 2024 (4 weeks ago) • Edgar (US Regulatory)
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Tuesday 2 April 2024 (1 month ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 26 March 2024 (1 month ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Saturday 17 February 2024 (3 months ago) • Edgar (US Regulatory)
Form PRE 14A - Other preliminary proxy statements
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 3 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)

More Vascular Biogenics Ltd. News Articles